Abrdn Life Sciences Investors Beheer
Beheer criteriumcontroles 1/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Dan Omstead
Algemeen directeur
n/a
Totale compensatie
Percentage CEO-salaris | n/a |
Dienstverband CEO | 23.8yrs |
Eigendom CEO | 0.7% |
Management gemiddelde ambtstermijn | geen gegevens |
Gemiddelde ambtstermijn bestuur | 18.8yrs |
Recente managementupdates
Recent updates
HQL: Hold Your Investments In This Healthcare CEF For Strong, Steady Yield
Sep 27HQL: 13% Discount Creates An Opportunity
Jun 29Tekla Life Sciences raises dividend by 6.5% to $0.33
Feb 15Tekla Life Sciences declines quarterly dividend by -11.4% to $0.31/share
Nov 16Tekla Life Sciences Investors: 10% Yield And Trading 10.5% Below NAV
Oct 23HQL: A Biotechnology Equity CEF With No Leverage
Jul 12HQL: Buy For The Yield, If You Can Stomach The Depreciation
Apr 27Tekla Life Sciences Investors: Buy For Steady, Quarterly Dividend
Feb 11Tekla Life Sciences Investors Rides Biotechnology Wave, Offers Growth With Steady Income
Sep 22Evaluating Closed-End Funds: HQL Is Another Fine Pick In A Hot Sector
Jun 29Tekla Life Sciences Investors: 8% Yield, 7% Discount
Jan 09Tekla Life Sciences declares $0.02 special dividend
Dec 21Tekla Life Sciences declares $0.40 dividend
Nov 16CEO
Dan Omstead (71 yo)
23.8yrs
Tenure
Dr. Daniel R. Omstead serves as Director at HotSpot Therapeutics, Inc. since April 2021. Dr. Omstead serves as the President since 2001, Chief Executive Officer, Chief Financial Officer, Manager, Trustee,...
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Principal Executive Officer | 21.8yrs | geen gegevens | 0.72% $ 2.9m | |
Trustee | 13.8yrs | US$26.50k | geen gegevens | |
Chairman | 24.8yrs | US$34.50k | geen gegevens | |
Independent Trustee | 32.8yrs | US$23.50k | geen gegevens | |
Trustee | 14.8yrs | US$30.75k | geen gegevens | |
Independent Trustee | 18.8yrs | US$28.00k | geen gegevens | |
Trustee | 17.8yrs | US$24.00k | geen gegevens | |
Trustee | no data | geen gegevens | 0.0037% $ 14.9k |
18.8yrs
Gemiddelde duur
75.5yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van HQL zijn ervaren en ervaren (gemiddelde ambtstermijn van 18.8 jaar).